145 related articles for article (PubMed ID: 31383301)
1. Immunoproteomic characterization of outer membrane vesicles from hyper-vesiculating Actinobacillus pleuropneumoniae.
Antenucci F; Magnowska Z; Nimtz M; Roesch C; Jänsch L; Bojesen AM
Vet Microbiol; 2019 Aug; 235():188-194. PubMed ID: 31383301
[TBL] [Abstract][Full Text] [Related]
2. Outer Membrane Vesicles of Actinobacillus pleuropneumoniae Exert Immunomodulatory Effects on Porcine Alveolar Macrophages.
Zhu Z; Antenucci F; Winther-Larsen HC; Skovgaard K; Bojesen AM
Microbiol Spectr; 2022 Oct; 10(5):e0181922. PubMed ID: 36040198
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of a common 48-kilodalton outer membrane protein of Actinobacillus pleuropneumoniae.
Cruz WT; Nedialkov YA; Thacker BJ; Mulks MH
Infect Immun; 1996 Jan; 64(1):83-90. PubMed ID: 8557378
[TBL] [Abstract][Full Text] [Related]
4. In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.
Antenucci F; Fougeroux C; Deeney A; Ørskov C; Rycroft A; Holst PJ; Bojesen AM
Vet Res; 2018 Jan; 49(1):4. PubMed ID: 29316978
[TBL] [Abstract][Full Text] [Related]
5. Immunoproteomic analysis of outer membrane proteins and extracellular proteins of Actinobacillus pleuropneumoniae JL03 serotype 3.
Liao Y; Deng J; Zhang A; Zhou M; Hu Y; Chen H; Jin M
BMC Microbiol; 2009 Aug; 9():172. PubMed ID: 19695095
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae.
Antenucci F; Fougeroux C; Bossé JT; Magnowska Z; Roesch C; Langford P; Holst PJ; Bojesen AM
Vet Res; 2017 Nov; 48(1):74. PubMed ID: 29122004
[TBL] [Abstract][Full Text] [Related]
7. Identification of conserved surface proteins as novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.
Chen X; Xu Z; Li L; Chen H; Zhou R
J Microbiol; 2012 Dec; 50(6):978-86. PubMed ID: 23274984
[TBL] [Abstract][Full Text] [Related]
8. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.
Dubreuil JD; Jacques M; Mittal KR; Gottschalk M
Anim Health Res Rev; 2000 Dec; 1(2):73-93. PubMed ID: 11708600
[TBL] [Abstract][Full Text] [Related]
9. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.
Loera-Muro A; Angulo C
Vet Microbiol; 2018 Apr; 217():66-75. PubMed ID: 29615259
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of a gene encoding an antigenic membrane protein from Actinobacillus pleuropneumoniae with homology to ABC transporters.
Martin PR; Mulks MH
FEMS Immunol Med Microbiol; 1999 Aug; 25(3):245-54. PubMed ID: 10459579
[TBL] [Abstract][Full Text] [Related]
11. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
van den Bosch H; Frey J
Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
[TBL] [Abstract][Full Text] [Related]
12.
Quan K; Zhu Z; Cao S; Zhang F; Miao C; Wen X; Huang X; Wen Y; Wu R; Yan Q; Huang Y; Ma X; Han X; Zhao Q
J Microbiol Biotechnol; 2018 Dec; 28(12):2095-2105. PubMed ID: 30380823
[TBL] [Abstract][Full Text] [Related]
13. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.
Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA
Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888
[TBL] [Abstract][Full Text] [Related]
14. Virulence factors of the swine pathogen Actinobacillus pleuropneumoniae.
Tascón RI; Vázquez-Boland JA; Gutiérrez-Martín CB; Rodríguez-Barbosa JI; Rodríguez-Ferri EF
Microbiologia; 1996 Jun; 12(2):171-84. PubMed ID: 8767702
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.
Oldfield NJ; Donovan EA; Worrall KE; Wooldridge KG; Langford PR; Rycroft AN; Ala'Aldeen DA
Vaccine; 2008 Apr; 26(16):1942-54. PubMed ID: 18342410
[TBL] [Abstract][Full Text] [Related]
16. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
[TBL] [Abstract][Full Text] [Related]
17. Antigenic differences within Actinobacillus pleuropneumoniae serotype 1.
Jolie RA; Mulks MH; Thacker BJ
Vet Microbiol; 1994 Feb; 38(4):329-49. PubMed ID: 8160348
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pig lungs following an experimental challenge with Actinobacillus pleuropneumoniae serotype 1 and 5 in pigs inoculated with either hemolysin protein and/or outer membrane proteins.
Madsen ME; Carnahan KG; Thwaits RN
FEMS Microbiol Lett; 1995 Sep; 131(3):329-35. PubMed ID: 7557344
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of the third antigenically distinct outer membrane lipoprotein (OmlA) in Actinobacillus pleuropneumoniae serotype 7.
Ito H; Osaki M; Uchida I; Ohya T; Sekizaki T
FEMS Microbiol Lett; 1998 Oct; 167(2):303-8. PubMed ID: 9809431
[TBL] [Abstract][Full Text] [Related]
20. Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae.
Li L; Sun C; Yang F; Yang S; Feng X; Gu J; Han W; Langford PR; Lei L
Vaccine; 2013 Oct; 31(45):5269-75. PubMed ID: 24051157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
